195 related articles for article (PubMed ID: 23457639)
1. Association of plasminogen activator inhibitor-type 1 (-675 4G/5G) polymorphism with pre-eclampsia: systematic review.
Morgan JA; Bombell S; McGuire W
PLoS One; 2013; 8(2):e56907. PubMed ID: 23457639
[TBL] [Abstract][Full Text] [Related]
2. Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis.
Zhao L; Bracken MB; Dewan AT; Chen S
Mol Hum Reprod; 2013 Mar; 19(3):136-43. PubMed ID: 23180602
[TBL] [Abstract][Full Text] [Related]
3. Correlation between plasminogen activator inhibitor-1 4G/5G polymorphism and pre-eclampsia: an appraisal.
Wiwanitkit V
Arch Gynecol Obstet; 2006 Mar; 273(6):322-4. PubMed ID: 16502012
[TBL] [Abstract][Full Text] [Related]
4. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with HELLP syndrome.
Muetze S; Eggermann T; Leeners B; Birke C; Kuse S; Ortlepp JR; Rudnik-Schoeneborn S; Zerres K; Rath W
J Thromb Thrombolysis; 2009 Feb; 27(2):141-5. PubMed ID: 18058192
[TBL] [Abstract][Full Text] [Related]
5. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia.
Yamada N; Arinami T; Yamakawa-Kobayashi K; Watanabe H; Sohda S; Hamada H; Kubo T; Hamaguchi H
J Hum Genet; 2000; 45(3):138-41. PubMed ID: 10807538
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.
Li X; Liu Y; Zhang R; Tan J; Chen L; Liu Y
Med Sci Monit; 2015 Apr; 21():1051-6. PubMed ID: 25862335
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 gene polymorphisms in pre-eclampsia.
D'Elia AV; Fabbro D; Driul L; Barillari G; Marchesoni D; Damante G
Semin Thromb Hemost; 2011 Mar; 37(2):97-105. PubMed ID: 21370208
[TBL] [Abstract][Full Text] [Related]
8. Association between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: a meta-analysis.
Li L; Nie W; Zhou H; Yuan W; Li W; Huang W
PLoS One; 2013; 8(1):e54883. PubMed ID: 23382992
[TBL] [Abstract][Full Text] [Related]
9. The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer.
Yıldırım ME; Karakuş S; Kurtulgan HK; Kılıçgün H; Erşan S; Bakır S
Biochem Genet; 2017 Aug; 55(4):314-321. PubMed ID: 28303356
[TBL] [Abstract][Full Text] [Related]
10. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
Lin S; Huiya Z; Bo L; Wei W; Yongmei G
Endocrine; 2009 Dec; 36(3):503-9. PubMed ID: 19856137
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
[TBL] [Abstract][Full Text] [Related]
12. The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.
Nie W; Li B; Xiu QY
PLoS One; 2012; 7(3):e34385. PubMed ID: 22479620
[TBL] [Abstract][Full Text] [Related]
13. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
[TBL] [Abstract][Full Text] [Related]
14. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia.
Fabbro D; D'Elia AV; Spizzo R; Driul L; Barillari G; Di Loreto C; Marchesoni D; Damante G
Gynecol Obstet Invest; 2003; 56(1):17-22. PubMed ID: 12867763
[TBL] [Abstract][Full Text] [Related]
15. Role of the tissue-type plasminogen activator -7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy.
Malle EM; Posch-Pertl L; Renner W; Pinter-Hausberger S; Singer C; Haas A; Wedrich A; Weger M
Ophthalmic Genet; 2018 Dec; 39(6):714-716. PubMed ID: 30442055
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.
Zhang Q; Jin Y; Li X; Peng X; Peng N; Song J; Xu M
Vasa; 2020 Mar; 49(2):141-146. PubMed ID: 31920171
[No Abstract] [Full Text] [Related]
17. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.
Hu X; Zan X; Xie Z; Li Y; Lin S; Li H; You C
Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513
[TBL] [Abstract][Full Text] [Related]
18. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
[TBL] [Abstract][Full Text] [Related]
19. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke.
Bang CO; Park HK; Ahn MY; Shin HK; Hwang KY; Hong SY
Cerebrovasc Dis; 2001; 11(4):294-9. PubMed ID: 11385207
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 polymorphism in women with pre-eclampsia.
Häkli T; Romppanen EL; Hiltunen M; Helisalmi S; Punnonen K; Heinonen S
Genet Test; 2003; 7(3):265-8. PubMed ID: 14642005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
